[The effect of antiphlogistic and immunosuppressive agents on the immune reaction and the protein-nucleic acid metabolism in adjuvant arthritis and experimental rheumatic processes].
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects*; D001168:Arthritis / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D003851:Deoxyribonucleases / Q000032:analysis; D005620:Freund's Adjuvant; D005938:Glucocorticoids / Q000032:analysis; D006639:Histidine / Q000031:analogs & derivatives; D007104:Immune Adherence Reaction; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009696:Nucleic Acids / Q000032:analysis / Q000378:metabolism*; D010070:Oxalates / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D011506:Proteins / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D012217:Rheumatoid Factor / Q000032:analysis; D012260:Ribonucleases / Q000032:analysis; D013291:Streptococcus / Q000276:immunology; D013386:Succinates / Q000627:therapeutic use
D000477:Alkylating Agents; D000893:Anti-Inflammatory Agents; D000907:Antibodies, Bacterial; D001323:Autoantibodies; D001798:Blood Proteins; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D009696:Nucleic Acids; D010070:Oxalates; D010648:Phenylacetates; D011506:Proteins; D013386:Succinates; D006639:Histidine; D005620:Freund's Adjuvant; D012217:Rheumatoid Factor; D003851:Deoxyribonucleases; D012260:Ribonucleases; D001241:Aspirin
Die Wirkung von antiphlogistischen und immunsuppressiven Präparaten auf Immunreaktionen und Eiweiss-Nukleinsäurestoffwechsel bei Adjufansarthritis und experimentellen rheumatischen Prozessen